{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T18:42:43Z","timestamp":1725907363598},"publisher-location":"New York, NY","reference-count":52,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493972180"},{"type":"electronic","value":"9781493972197"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7219-7_18","type":"book-chapter","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T14:48:19Z","timestamp":1502203699000},"page":"275-293","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Specificity of an Adenovirus Targeted to HER3\/4"],"prefix":"10.1007","author":[{"given":"Sheena H.","family":"MacLeod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle G.","family":"Potts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyambabu","family":"Chaurasiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Hitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"21","key":"18_CR1","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.18632\/oncotarget.2655","volume":"5","author":"K Mujoo","year":"2014","unstructured":"Mujoo K, Choi B-K, Huang Z, Zhang N, An Z (2014) Regulation of ERBB3\/HER3 signaling in cancer. Oncotarget 5(21):10222\u201310236","journal-title":"Oncotarget"},{"issue":"7","key":"18_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/cgt.2008.15","volume":"15","author":"G Sithanandam","year":"2008","unstructured":"Sithanandam G, Anderson LM (2008) The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther 15(7):413\u2013448","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"18_CR3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molmed.2007.10.002","volume":"13","author":"NV Sergina","year":"2007","unstructured":"Sergina NV, Moasser MM (2007) The HER family and cancer: emerging molecular mechanisms and therapeutic targets. Trends Mol Med 13(12):527\u2013534","journal-title":"Trends Mol Med"},{"issue":"2","key":"18_CR4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.critrevonc.2009.04.011","volume":"74","author":"AK Koutras","year":"2010","unstructured":"Koutras AK, Fountzilas G, Kalogeras KT, Starakis I, Iconomou G, Kalofonos HP (2010) The upgraded role of HER3 and HER4 receptors in breast cancer. Crit Rev Oncol Hematol 74(2):73\u201378","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"18_CR5","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/bcr2339","volume":"11","author":"A Sassen","year":"2009","unstructured":"Sassen A, Diermeier-Daucher S, Sieben M, Ortmann O, Hofstaedter F, Schwarz S et al (2009) Presence of HER4 associates with increased sensitivity to Herceptin\u2122 in patients with metastatic breast cancer. Breast Cancer Res 11(4):R50","journal-title":"Breast Cancer Res"},{"issue":"1","key":"18_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2016.01.045","volume":"470","author":"S Okazaki","year":"2016","unstructured":"Okazaki S, Nakatani F, Masuko K, Tsuchihashi K, Ueda S, Masuko T et al (2016) Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells. Biochem Biophys Res Commun 470(1):239\u2013244","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"18_CR7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/cgt.2012.79","volume":"19","author":"SH MacLeod","year":"2012","unstructured":"MacLeod SH, Elgadi MM, Bossi G, Sankar U, Pisio A, Agopsowicz K et al (2012) HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice. Cancer Gene Ther 19(12):888\u2013898","journal-title":"Cancer Gene Ther"},{"key":"18_CR8","unstructured":"Wiley J and Sons (2016) Vectors used in gene therapy clinical trials. http:\/\/www.wiley.com\/legacy\/wileychi\/genmed\/clinical\/ . Accessed 22 Jun 2016"},{"key":"18_CR9","first-page":"2664","volume-title":"Fields virology","author":"AJ Berk","year":"2013","unstructured":"Berk AJ (2013) Adenoviridae. In: Knipe DM, Howley P (eds) Fields virology, 6th edn. Lipincott, Williams & Wilkins, Philadelphia, p 2664","edition":"6th"},{"issue":"6","key":"18_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","volume":"13","author":"WSM Wold","year":"2013","unstructured":"Wold WSM, Toth K (2013) Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther 13(6):421\u2013433","journal-title":"Curr Gene Ther"},{"issue":"19","key":"18_CR11","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.91.19.8802","volume":"91","author":"AJ Bett","year":"1994","unstructured":"Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91(19):8802\u20138806","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"18_CR12","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.gt.3301301","volume":"7","author":"X Danthinne","year":"2000","unstructured":"Danthinne X, Imperiale MJ (2000) Production of first generation adenovirus vectors: a review. Gene Ther 7(20):1707\u20131714","journal-title":"Gene Ther"},{"key":"18_CR13","doi-asserted-by":"crossref","unstructured":"Yoon A-R, Hong J, Kim SW, Yun C-O (2016) Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy. Expert Opin Drug Deliv 13(6):843\u2013858","DOI":"10.1517\/17425247.2016.1158707"},{"issue":"3","key":"18_CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425247.2014.874414","volume":"11","author":"D Kasala","year":"2014","unstructured":"Kasala D, Choi J-W, Kim SW, Yun C-O (2014) Utilizing adenovirus vectors for gene delivery in cancer. Expert Opin Drug Deliv 11(3):379\u2013392","journal-title":"Expert Opin Drug Deliv"},{"issue":"2","key":"18_CR15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/v6020832","volume":"6","author":"C Capasso","year":"2014","unstructured":"Capasso C, Garofalo M, Hirvinen M, Cerullo V (2014) The evolution of adenoviral vectors through genetic and chemical surface modifications. Viruses 6(2):832\u2013855","journal-title":"Viruses"},{"issue":"6","key":"18_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/cgt.2016.18","volume":"23","author":"S Chaurasiya","year":"2016","unstructured":"Chaurasiya S, Hew P, Crosley P, Sharon D, Potts K, Agopsowicz K et al (2016) Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin promoter\/enhancer sequences. Cancer Gene Ther 23(6):178\u2013187","journal-title":"Cancer Gene Ther"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-9966-29-52","volume":"29","author":"J-F Zhang","year":"2010","unstructured":"Zhang J-F, Wei F, Wang H-P, Li H-M, Qiu W, Ren P-K et al (2010) Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo. J Exp Clin Cancer Res 29:52","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"18_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.cgt.7700666","volume":"11","author":"J Irving","year":"2004","unstructured":"Irving J, Wang Z, Powell S, O\u2019Sullivan C, Mok M, Murphy B et al (2004) Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. Cancer Gene Ther 11(3):174\u2013185","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"18_CR19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/1566523054546189","volume":"5","author":"H Sadeghi","year":"2005","unstructured":"Sadeghi H, Hitt MM (2005) Transcriptionally targeted adenovirus vectors. Curr Gene Ther 5(4):411\u2013427","journal-title":"Curr Gene Ther"},{"issue":"2","key":"18_CR20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urology.2005.02.033","volume":"66","author":"K Matsumoto","year":"2005","unstructured":"Matsumoto K, Shariat SF, Ayala GE, Rauen KA, Lerner SP (2005) Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66(2):441\u2013446","journal-title":"Urology"},{"issue":"24","key":"18_CR21","first-page":"5738","volume":"58","author":"CR Miller","year":"1998","unstructured":"Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS et al (1998) Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 58(24):5738\u20135748","journal-title":"Cancer Res"},{"issue":"12","key":"18_CR22","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","volume":"72","author":"I Dmitriev","year":"1998","unstructured":"Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G et al (1998) An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 72(12):9706\u20139713","journal-title":"J Virol"},{"issue":"3","key":"18_CR23","first-page":"813","volume":"61","author":"JT Douglas","year":"2001","unstructured":"Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT (2001) Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors. Cancer Res 61(3):813\u2013817","journal-title":"Cancer Res"},{"issue":"6","key":"18_CR24","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1128\/JVI.76.6.2753-2762.2002","volume":"76","author":"VW Beusechem van","year":"2002","unstructured":"van Beusechem VW, Grill J, Mastenbroek DCJ, Wickham TJ, Roelvink PW, Haisma HJ et al (2002) Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J Virol 76(6):2753\u20132762","journal-title":"J Virol"},{"issue":"2","key":"18_CR25","first-page":"609","volume":"62","author":"EA Kashentseva","year":"2002","unstructured":"Kashentseva EA, Seki T, Curiel DT, Dmitriev IP (2002) Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. Cancer Res 62(2):609\u2013616","journal-title":"Cancer Res"},{"issue":"15","key":"18_CR26","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1128\/JVI.74.15.6875-6884.2000","volume":"74","author":"I Dmitriev","year":"2000","unstructured":"Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT (2000) Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells. J Virol 74(15):6875\u20136884","journal-title":"J Virol"},{"issue":"Pt 9","key":"18_CR27","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1099\/vir.0.81620-0","volume":"87","author":"R Lord","year":"2006","unstructured":"Lord R, Parsons M, Kirby I, Beavil A, Hunt J, Sutton B et al (2006) Analysis of the interaction between RGD-expressing adenovirus type 5 fiber knob domains and alphavbeta3 integrin reveals distinct binding profiles and intracellular trafficking. J Gen Virol 87(Pt 9):2497\u20132505","journal-title":"J Gen Virol"},{"issue":"3","key":"18_CR28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.gt.3302859","volume":"14","author":"S Kurachi","year":"2007","unstructured":"Kurachi S, Koizumi N, Sakurai F, Kawabata K, Sakurai H, Nakagawa S et al (2007) Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon. Gene Ther 14(3):266\u2013274","journal-title":"Gene Ther"},{"issue":"3","key":"18_CR29","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/JVI.72.3.1844-1852.1998","volume":"72","author":"V Krasnykh","year":"1998","unstructured":"Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT (1998) Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 72(3):1844\u20131852","journal-title":"J Virol"},{"issue":"3","key":"18_CR30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cgt.2008.75","volume":"16","author":"Y Piao","year":"2009","unstructured":"Piao Y, Jiang H, Alemany R, Krasnykh V, Marini FC, Xu J et al (2009) Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity. Cancer Gene Ther 16(3):256\u2013265","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"18_CR31","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jgm.348","volume":"5","author":"N Koizumi","year":"2003","unstructured":"Koizumi N, Mizuguchi H, Utoguchi N, Watanabe Y, Hayakawa T (2003) Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob. J Gene Med 5(4):267\u2013276","journal-title":"J Gene Med"},{"issue":"5","key":"18_CR32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.cgt.7701027","volume":"14","author":"MK Magnusson","year":"2007","unstructured":"Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, Friedman M et al (2007) Adenovirus 5 vector genetically re-targeted by an affibody molecule with specificity for tumor antigen HER2\/neu. Cancer Gene Ther 14(5):468\u2013479","journal-title":"Cancer Gene Ther"},{"issue":"14","key":"18_CR33","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1128\/JVI.76.14.6893-6899.2002","volume":"76","author":"IP Dmitriev","year":"2002","unstructured":"Dmitriev IP, Kashentseva EA, Curiel DT (2002) Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J Virol 76(14):6893\u20136899","journal-title":"J Virol"},{"issue":"19","key":"18_CR34","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.02665-09","volume":"84","author":"KL Poulin","year":"2010","unstructured":"Poulin KL, Lanthier RM, Smith AC, Christou C, Risco Quiroz M, Powell KL et al (2010) Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. J Virol 84(19):10074\u201310086","journal-title":"J Virol"},{"issue":"6","key":"18_CR35","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.73.6.5156-5161.1999","volume":"73","author":"E Vigne","year":"1999","unstructured":"Vigne E, Mahfouz I, Dedieu JF, Brie A, Perricaudet M, Yeh P (1999) RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection. J Virol 73(6):5156\u20135161","journal-title":"J Virol"},{"issue":"11","key":"18_CR36","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1089\/hum.2004.15.1125","volume":"15","author":"SK Campos","year":"2004","unstructured":"Campos SK, Barry MA (2004) Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombination. Hum Gene Ther 15(11):1125\u20131130","journal-title":"Hum Gene Ther"},{"issue":"10","key":"18_CR37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","volume":"2","author":"L Coughlan","year":"2010","unstructured":"Coughlan L, Alba R, Parker AL, Bradshaw AC, McNeish IA, Nicklin SA et al (2010) Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses 2(10):2290\u20132355","journal-title":"Viruses"},{"issue":"3","key":"18_CR38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1096\/fj.04-3180fje","volume":"19","author":"MR Soboleski","year":"2005","unstructured":"Soboleski MR, Oaks J, Halford WP (2005) Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J 19(3):440\u2013442","journal-title":"FASEB J"},{"key":"18_CR39","doi-asserted-by":"publisher","unstructured":"Smale ST (2010) Luciferase assay. Cold Spring Harb Protoc. doi: 10.1101\/pdb.prot5421","DOI":"10.1101\/pdb.prot5421"},{"issue":"6","key":"18_CR40","first-page":"631","volume":"54","author":"A Sato","year":"2004","unstructured":"Sato A, Klaunberg B, Tolwani R (2004) In vivo bioluminescence imaging BLI\u00a0: an overview. Comp Med 54(6):631\u2013634","journal-title":"Comp Med"},{"key":"18_CR41","doi-asserted-by":"crossref","unstructured":"Potts KG, Favis NA, Pink DB, Vincent KM, Lewis JD, Moore RB, Hitt MM, Evans D (2017) Oncolytic vaccinia virus F4L (ribonucleotide reductase) mutants promote anti-tumor immunity with superior safety in bladder cancer models. EMBO Mol Med 9(5):638\u2013654","DOI":"10.15252\/emmm.201607296"},{"issue":"1","key":"18_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/mthe.2000.0222","volume":"3","author":"DK Hoganson","year":"2001","unstructured":"Hoganson DK, Sosnowski BA, Pierce GF, Doukas J (2001) Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand. Mol Ther 3(1):105\u2013112","journal-title":"Mol Ther"},{"issue":"4","key":"18_CR43","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ymthe.2004.01.012","volume":"9","author":"RA Meulenbroek","year":"2004","unstructured":"Meulenbroek RA, Sargent KL, Lunde J, Jasmin BJ, Parks RJ (2004) Use of adenovirus protein IX (pIX) to display large polypeptides on the virion\u2013generation of fluorescent virus through the incorporation of pIX-GFP. Mol Ther 9(4):617\u2013624","journal-title":"Mol Ther"},{"issue":"11","key":"18_CR44","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.mt.6300283","volume":"15","author":"S Rog\u00e9e","year":"2007","unstructured":"Rog\u00e9e S, Grellier E, Bernard C, Loyens A, Beauvillain J-C, D\u2019halluin J-C et al (2007) Intracellular trafficking of a fiber-modified adenovirus using lipid raft\/caveolae endocytosis. Mol Ther 15(11):1963\u20131972","journal-title":"Mol Ther"},{"issue":"3","key":"18_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/hum.1998.9.3-367","volume":"9","author":"PL Leopold","year":"1998","unstructured":"Leopold PL, Ferris B, Grinberg I, Worgall S, Hackett NR, Crystal RG (1998) Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther 9(3):367\u2013378","journal-title":"Hum Gene Ther"},{"key":"18_CR46","unstructured":"MacLeod SH (2013) Binding, internalization, and transgene expression of an adenoviral vector retargeted to HER3\/4. Dissertation, University of Alberta"},{"issue":"10","key":"18_CR47","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/jps.20157","volume":"93","author":"RK Evans","year":"2004","unstructured":"Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S et al (2004) Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci 93(10):2458\u20132475","journal-title":"J Pharm Sci"},{"key":"18_CR48","first-page":"151","volume-title":"Canadian biosafety standard","author":"Public Health Agency of Canada","year":"2015","unstructured":"Public Health Agency of Canada (2015) Canadian biosafety standard. Public Health Agency of Canada, Ottawa, p 151"},{"issue":"24","key":"18_CR49","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1073\/pnas.93.24.13565","volume":"93","author":"RJ Parks","year":"1996","unstructured":"Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL (1996) A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A 93(24):13565\u201313570","journal-title":"Proc Natl Acad Sci U S A"},{"key":"18_CR50","volume-title":"Monoclonal antibody production","author":"National Research Council (US) Committee on Methods of Producing Monoclonal Antibodies","year":"1999","unstructured":"National Research Council (US) Committee on Methods of Producing Monoclonal Antibodies (1999) In vitro production of monoclonal antibody. In: Monoclonal antibody production. National Academies Press (US), Washington (DC)"},{"key":"18_CR51","first-page":"3280","volume-title":"Fields virology","author":"RC Condit","year":"2001","unstructured":"Condit RC (2001) Principles of virology. In: Knipe DK, Howley PM (eds) Fields virology, 4th edn. Lippincott-Raven, Philadelphia, USA, p 3280","edition":"4th"},{"issue":"3","key":"18_CR52","first-page":"59","volume":"1","author":"G Bilbao","year":"1998","unstructured":"Bilbao G, Contreras JL, Gomez-Navarro J, Curiel DT (1998) Improving adenoviral vectors for cancer gene therapy. Tumor Target 1(3):59\u201379","journal-title":"Tumor Target"}],"container-title":["Methods in Molecular Biology","ErbB Receptor Signaling"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7219-7_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:05:44Z","timestamp":1602680744000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7219-7_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493972180","9781493972197"],"references-count":52,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7219-7_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017]]}}}